✉news HealthMedicine first seen 17 h ago, last 1 h ago, peak #1
Single CRISPR Treatment Halves Bad Cholesterol for a Year
Original: One CRISPR treatment cut “bad” cholesterol in half for a full year
A one-time CRISPR gene-editing treatment cut LDL, the so-called "bad" cholesterol, roughly in half, with the effect lasting a full year after a single infusion, according to new findings reported by ScienceDaily. The results point toward a durable alternative to daily statins or repeated injections for people at risk of heart disease.
Why now: New published results showing a lasting cholesterol reduction from a single gene-editing dose are generating attention about the future of heart disease treatment.
Rank over time, top of the chart is #1. 18 snapshots from 17 h ago to 1 h ago.
Evidence
- One CRISPR treatment cut “bad” cholesterol in half for a full year · sciencedaily.com
- One CRISPR treatment cut “bad” cholesterol in half for a full year · ScienceDaily
API: https://socialmediatrends-api.osmike.com/v1/trends/115633